Design Therapeutics, Inc. (Nasdaq:DSGN)
Health Care/Life Sciences • Biotechnology
CIK 1807120
Company
Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.
Address
6005 Hidden Valley Road
Suite 110
Carlsbad, California 92011
6005 Hidden Valley Road
Suite 110
Carlsbad, California 92011
Employees
124
124
Stock Info
Close
$4.9350
$4.9350
Day Range
4.7300 - 5.1000
4.7300 - 5.1000
52 Week Range
2.4501 - 7.7700
2.4501 - 7.7700
Average volume
186.91K
186.91K
Short Interest
3.14M (02/14/25)
3.14M (02/14/25)
% of Float Shorted
10.19%
10.19%
Market Cap
$279.42M
$279.42M
Revenue
N/A
N/A
Net Income
-$66.86M
-$66.86M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Executive Chairman, President, CEO & CFO Pratik Shah |
Independent Director Arsani Hany William |
Independent Director John P. Schmid |
Independent Director Heather Behanna |
Independent Director Deepa Prasad |
Independent Director Rodney W. Lappe |
Lead Independent Director Simeon J. George |
SEC filings
Date | Form | Event |
---|---|---|
19 Dec, 2024 | 4 | |
7 Nov, 2024 | 8-K | |
7 Nov, 2024 | 10-Q | |
13 Aug, 2024 | SC 13D/A | |
12 Aug, 2024 | 4 | |
9 Aug, 2024 | 144 | |
5 Aug, 2024 | 10-Q | |
5 Aug, 2024 | 8-K | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 8-K | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 4 | |
8 May, 2024 | 10-Q | |
8 May, 2024 | 8-K | |
25 Apr, 2024 | DEF 14A | |
25 Apr, 2024 | DEFA14A | |
25 Apr, 2024 | ARS | |
25 Mar, 2024 | 4 | |
25 Mar, 2024 | 4 | |
20 Mar, 2024 | 3 | |
19 Mar, 2024 | 8-K | |
19 Mar, 2024 | S-8 | |
19 Mar, 2024 | 10-K | |
14 Feb, 2024 | SC 13G/A | |
14 Feb, 2024 | SC 13G/A | |
23 Jan, 2024 | SC 13G/A | |
5 Jan, 2024 | 4 | |
5 Jan, 2024 | 4 | |
5 Dec, 2023 | 4 | |
5 Dec, 2023 | 4 | |
14 Nov, 2023 | SC 13G/A | |
13 Nov, 2023 | 10-Q | |
13 Nov, 2023 | 8-K | |
2 Oct, 2023 | 4 | |
7 Sep, 2023 | SC 13G/A | |
6 Sep, 2023 | 4/A | |
5 Sep, 2023 | 4 | |
30 Aug, 2023 | 4 | |
30 Aug, 2023 | 4 | |
25 Aug, 2023 | 8-K | CEO Change |
14 Aug, 2023 | 10-Q | |
14 Aug, 2023 | 8-K | |
2 Jun, 2023 | 4 | |
2 Jun, 2023 | 4 | |
2 Jun, 2023 | 4 | |
2 Jun, 2023 | 4 | |
2 Jun, 2023 | 4 | |
2 Jun, 2023 | 4 | |
2 Jun, 2023 | 4 | |
1 Jun, 2023 | 8-K | |
9 May, 2023 | 8-K | |
9 May, 2023 | 10-Q | |
13 Apr, 2023 | DEFA14A | |
13 Apr, 2023 | DEF 14A | |
13 Apr, 2023 | ARS | |
3 Apr, 2023 | SC 13G | |
14 Mar, 2023 | 8-K | |
14 Mar, 2023 | S-8 | |
14 Mar, 2023 | 10-K | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
8 Feb, 2023 | SC 13G | |
3 Feb, 2023 | 4 | |
3 Feb, 2023 | 4 | |
3 Feb, 2023 | SC 13G | |
3 Feb, 2023 | 4 | |
3 Feb, 2023 | 4 | |
22 Dec, 2022 | SC 13G | |
22 Dec, 2022 | SC 13D/A | |
21 Dec, 2022 | 4 | |
20 Dec, 2022 | 4 | |
20 Dec, 2022 | 4 | |
12 Dec, 2022 | 4 | |
3 Nov, 2022 | 8-K | |
3 Nov, 2022 | 10-Q | |
13 Oct, 2022 | SC 13G | |
8 Aug, 2022 | 10-Q | |
8 Aug, 2022 | 8-K | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 8-K | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 4 | |
9 May, 2022 | 8-K | |
9 May, 2022 | 10-Q | |
9 May, 2022 | EFFECT | |
5 May, 2022 | CORRESP | |
2 May, 2022 | CORRESP | |
29 Apr, 2022 | UPLOAD | |
27 Apr, 2022 | DEF 14A | |
27 Apr, 2022 | S-3 | |
27 Apr, 2022 | DEFA14A | |
31 Mar, 2022 | SC 13D | |
22 Mar, 2022 | 4 | |
22 Mar, 2022 | 8-K | |
22 Mar, 2022 | 4 | |
18 Mar, 2022 | 4 | |
10 Mar, 2022 | 10-K | |
10 Mar, 2022 | S-8 | |
10 Mar, 2022 | 8-K | |
14 Feb, 2022 | SC 13G/A | |
9 Feb, 2022 | SC 13G | |
9 Feb, 2022 | SC 13G | |
9 Feb, 2022 | SC 13G | |
2 Feb, 2022 | 4 | |
2 Feb, 2022 | 4 | |
2 Feb, 2022 | 4 | |
2 Feb, 2022 | 4 | |
9 Nov, 2021 | 10-Q | |
9 Nov, 2021 | 8-K | |
4 Oct, 2021 | 4 | |
20 Sep, 2021 | 3 | |
2 Sep, 2021 | 4 | |
20 Aug, 2021 | 8-K | |
17 Aug, 2021 | 3 | |
9 Aug, 2021 | 10-Q | |
9 Aug, 2021 | 8-K | |
6 Aug, 2021 | 8-K | |
16 Jun, 2021 | 4 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 4 | |
16 Jun, 2021 | 3 | |
7 Jun, 2021 | 8-K | |
10 May, 2021 | 10-Q | |
10 May, 2021 | 8-K | |
9 Apr, 2021 | SC 13G | |
9 Apr, 2021 | SC 13D | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
30 Mar, 2021 | 8-K | |
30 Mar, 2021 | 3/A | |
29 Mar, 2021 | 4 | |
29 Mar, 2021 | 4 | |
29 Mar, 2021 | 4 | |
29 Mar, 2021 | 4 | |
29 Mar, 2021 | 4 | |
26 Mar, 2021 | 424B4 | IPO completed |
26 Mar, 2021 | S-8 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | EFFECT | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
24 Mar, 2021 | SEC STAFF | |
24 Mar, 2021 | CERT | |
23 Mar, 2021 | CORRESP | |
23 Mar, 2021 | 8-A12B | |
23 Mar, 2021 | CORRESP | |
22 Mar, 2021 | S-1/A | |
22 Mar, 2021 | CORRESP | |
18 Mar, 2021 | UPLOAD | |
16 Mar, 2021 | CORRESP | |
5 Mar, 2021 | CORRESP | |
5 Mar, 2021 | S-1 | |
23 Feb, 2021 | SEC STAFF | |
23 Feb, 2021 | UPLOAD | |
12 Feb, 2021 | D | |
26 Jan, 2021 | DRS |
Last update:2025-03-06 13:27:03.498496
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.